Background: CSHP 2015 objective 1.5 proposes that at least 50% of recently hospitalized patients or their caregivers will recall speaking with a pharmacist while in the hospital.
Objective: To determine the baseline prevalence of patients' recall of interaction with a pharmacist during their hospital admission and their level of satisfaction with these encounters, following a major reorganization of health authorities in New Brunswick.
Methods: Former inpatients from 27 units in 9 hospitals in the Horizon Health Network were randomly selected to complete a telephone survey within 5 to 7 months after discharge from hospital. Patients' responses were validated against pharmacists' documentation in the patients' health records.
Results: From June 2010 to July 2011, a total of 1028 former inpatients were screened, of whom 399 completed the telephone survey. More than half of the respondents were women (225 [56.4%]), and the mean age was 67 years. Overall, 184 patients (46.1%) recalled speaking with a pharmacist during their recent admission. Of these, 164 (89.1%) were "satisfied" or "very satisfied" with these interactions. In addition, 332 respondents (83.2%) indicated that if the hospital offered the opportunity to talk with a pharmacist who could help answer their questions about medications, they would take advantage of this service. The electronic hospital records of 181 patients (from 15 units at 3 sites) were analyzed to seek evidence of pharmacists' interventions or encounters (e.g., medication history, consultation). Pharmacist documentation was found in the health records of 166 (91.7%) of all patients in this sample.
Conclusions: Almost half of former inpatients recalled speaking with a pharmacist during a recent hospital admission. The majority of patients were satisfied with these interactions and would welcome future services from hospital pharmacists.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694938 | PMC |
http://dx.doi.org/10.4212/cjhp.v66i3.1254 | DOI Listing |
J Cardiothorac Surg
January 2025
Department of Pharmacy, The First Hospital of Lanzhou University, Lanzhou, Gansu Province, 730000, China.
Objective: The prevalence and characteristics of drug-related problems (DRPs) in the cardiovascular surgery unit have not been adequately explored, leaving a gap in our understanding of this critical issue. This study aimed to address this gap by determining the prevalence, characteristics of DRPs and identifying factors associated with their occurrence.
Methods: During a non-consecutive 48-month study period, a retrospective analysis was conducted to investigate DRPs and the interventions carried out by pharmacists for patients undergoing cardiovascular surgery.
Int J Clin Pharm
January 2025
Pharmacy Practice and Pharmacotherapeutics Department, College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates.
Background: Fragmented healthcare systems hinder pharmacists' access to comprehensive patient data, limiting their clinical role and posing health risks. Enhancing system interoperability and evaluating factors influencing pharmacists' readiness for technology-driven practice change is a crucial step.
Aim: This systematic review aimed to investigate the digital determinants of pharmacists' readiness for technology-oriented practice change and interoperability.
ANZ J Surg
January 2025
Lyell McEwin Hospital, Adelaide, South Australia, Australia.
Background: The Adelaide Score is an artificial intelligence system that integrates objective vital signs and laboratory tests to predict likelihood of hospital discharge.
Methods: A prospective implementation trial was conducted at the Lyell McEwin Hospital in South Australia. The Adelaide Score was added to existing human, artificial intelligence, and other technological infrastructure for the first 28 days of April 2024 (intervention), and outcomes were compared using parametric, non-parametric and health economic analyses, to those in the first 28 days of April 2023 (control).
Introduction: Pediatric patients are more likely to experience medication-related errors and serious associated harms. The identification of high-risk medications (HRM) and their study in special populations, such as children with excess body weight (EBW), is a part of safety improvement strategies.
Objective: To generate, through a consensus technique structured by an interdisciplinary group of pediatricians and hospital pharmacists, an operational and updated list of HRM for hospital use in children over 2 years of age.
J Food Drug Anal
December 2024
School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan.
Non-small cell lung cancer (NSCLC) is commonly treated with tyrosine kinase inhibitors (TKIs). However, adverse events from such treatment can lead to treatment discontinuation and additional medical expenditures. Ambulatory care from oncology pharmacists in patient education and symptom management can benefit patients with NSCLC.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!